Loading data for QCLS — first visit, this takes a few seconds.
Q/C Technologies Inc. (QCLS)
NasdaqCM: QCLS
· Echtzeitkurs · USD
2.89
+0.00 (0.00%)
Zum Schluss: Aug 18, 2026, 3:59 PM
2.87
-0.81%
Vorbörslich: 4:16 AM
Q/C Technologies Inc. (QCLS) Stock Price, Analysis & Data
0.00% (1D)
| Geld | 2.09 |
| Marktkapitalisierung | 22.7 Mio |
| Umsatz (TTM) | n/a |
| Nettogewinn (TTM) | -14.57 Mio |
| Beta | 2.11 |
| EPS (ttm) | -8.61 |
| KGV (TTM) | n/a |
| Forward-KGV | n/a |
| KBV (TTM) | 1.10 |
| KUV (TTM) | n/a |
| Earnings Date | n/a |
| Brief | 3.64 |
| Volumen | 48,350 |
| Ø Vol. (20D) | 348,341 |
| Eröffnung | 2.93 |
| Vortagesschluss | 2.89 |
| Tagesspanne | 2.85 - 2.95 |
| 52-Wk Range | 2.50 - 10.80 |
| Analyst | n/a |
| Kursziel | n/a |
| Dividenden | n/a |
| Ex-Dividenden-Datum | n/a |
Über QCLS
Q/C Technologies, Inc. operates as a clinical-stage pharmaceutical company. It operates through Pharmaceuticals and Computing Technology segments. The company develops Isomyosamine, a clinical stage small molecule that regulates the immunometabolic system to treat autoimmune disease, including sarcopenia, frailty, adverse effects of drugs used to treat diabetes and obesity, rheumatoid arthritis, and inflammatory bowel disease. It also develops Su...
Branche Computer Hardware
Sektor Technology
IPO Datum Jan 23, 2014
Mitarbeiter 3
Börse NasdaqCM
Tickersymbol QCLS
Website https://www.qctechnologies.com
Finanzielle Entwicklung
Im Jahr 2025 betrug der Umsatz von Q/C 0, ein Anstieg von undefined% im Vergleich zum Vorjahr (0). Der Gewinn lag bei -11.63 Mio, ein Rückgang von -50.22 %.
Finanzberichte